Roald Brouwer Buys 2,000 Shares of Amrize (NYSE:AMRZ) Stock

Key Points

• Insider buy: CTO Roald Brouwer purchased 2,000 shares of Amrize on March 13 at an average price of $54.88 (~$109,760), adding to a March 11 purchase of 3,000 shares, boosting his stake 12.30% to 18,257 shares (~$1.00M) — disclosed in an SEC filing.
• Recent results and market data: AMRZ traded at $55.97 (up 0.8%), has a market cap of ~$30.96B and a P/E of 22.74; the company beat EPS estimates ($0.62 vs. $0.59) but missed revenue expectations ($2.84B vs. $2.95B).
• Analyst view: Consensus rating is a "Moderate Buy" with an average price target of $64.14, and several firms (Wells Fargo, Truist, JPMorgan) recently raised targets or reiterated positive ratings.

Amrize Ltd (NYSE:AMRZ - Get Free Report) CTO Roald Brouwer bought 2,000 shares of the firm's stock in a transaction on Friday, March 13th. The shares were purchased at an average cost of $54.88 per share, with a total value of $109,760.00. Following the transaction, the chief technology officer directly owned 18,257 shares in the company, valued at approximately $1,001,944.16. This trade represents a 12.30% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Roald Brouwer also recently made the following trade(s):

• On Wednesday, March 11th, Roald Brouwer purchased 3,000 shares of Amrize stock. The shares were purchased at an average price of $58.72 per share, with a total value of $176,160.00.

Amrize Trading Up 0.8%

Shares of NYSE AMRZ traded up $0.42 during midday trading on Monday, reaching $55.97. The stock had a trading volume of 1,656,224 shares, compared to its average volume of 3,563,369. The company's 50 day moving average price is $57.93 and its 200 day moving average price is $53.69. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The firm has a market cap of $30.96 billion and a price-to-earnings ratio of 22.74.

Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.03. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The company's revenue was down .4% compared to the same quarter last year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on AMRZ shares. Sanford C. Bernstein reiterated an "outperform" rating and set a $70.00 price target on shares of Amrize in a report on Thursday, December 18th. Wells Fargo & Company upped their target price on Amrize from $59.00 to $66.00 and gave the company an "overweight" rating in a research report on Thursday, February 19th. Truist Financial raised their target price on Amrize from $60.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, February 20th. JPMorgan Chase & Co. lifted their target price on Amrize from $60.00 to $70.00 and gave the stock an "overweight" rating in a report on Thursday, March 5th. Finally, Berenberg Bank set a $70.00 price target on Amrize in a research note on Thursday, February 19th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Amrize has a consensus rating of "Moderate Buy" and an average price target of $64.14.

Institutional Investors Weigh In On Amrize

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Mengis Capital Management Inc. boosted its position in shares of Amrize by 8.5% during the 4th quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company's stock worth $311,000 after purchasing an additional 450 shares in the last quarter. Groupama Asset Managment grew its stake in shares of Amrize by 12.7% in the 4th quarter. Groupama Asset Managment now owns 28,889 shares of the company's stock valued at $1,562,000 after buying an additional 3,254 shares during the period. Alpine Global Management LLC bought a new stake in Amrize in the 4th quarter valued at about $1,893,000. MidFirst Bank acquired a new position in Amrize during the 4th quarter worth approximately $187,000. Finally, River Road Asset Management LLC raised its stake in Amrize by 26.1% during the 4th quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company's stock worth $155,942,000 after buying an additional 597,542 shares during the period.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.